MedTrace Logo

Prognostic Tools in Patients With Acute Pulmonary Thromboembolism.

NCT04237974 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-04-01

No results posted yet for this study

Summary

Acute pulmonary embolism (PE) is a serious disease associated with high mortality rates despite advanced therapeutic options. The treatment options depend on the severity of the disease and the short - term mortality varies widely from 2 to 95%, depending on the severity of the condition

Conditions

Interventions

DEVICE

computed tomography pulmonary angiography

The radiological severity of pulmonary embolism will be assessed by using the computed tomography pulmonary arterial obstruction index (CT-PAOI)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Yousef A Yousef, Professor · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2023-04-30
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04237974 on ClinicalTrials.gov